Samsung Medical Center at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Samsung Medical Center takes part in 5 sessions at CTAD 2026 in Boston. Its program centres on lecanemab treatment in Korea, from amyloid PET monitoring to cardiovascular changes and ARIA. Its work also covers air pollution and early-onset Alzheimer's disease and plasma p-tau217 cutoffs in an Asian cohort.

Organization	CTAD 2026 Attendance
Samsung Medical Center Seoul, South Korea
	Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Burden-dependent bias of cerebellar reference regions in amyloid PET monitoring of disease-modifying therapy: eroded white matter as a calibratable anchor (P096) PET and MRI imaging Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Stronger Association of PM2.5 Exposure with Early-Onset Alzheimer’s Disease and Distinct Vulnerability Profiles: A Nationwide 16-Year Cohort Study with Supporting Evidence from iPSC-Derived Neurons (P162) Prevention and early disease Poster Wed Nov 18 7:15am–5:30pm Temporal plasma proteomic responses to lecanemab and their associations with amyloid clearance and cognitive change: a multicentre, real-world cohort study (P227) Anti-amyloid and anti-tau therapies · Blood and CSF biomarkers Poster Wed Nov 18 7:15am–5:30pm Diagnostic accuracy of Elecsys pTau181 and pTau217 plasma assays using global cutoffs in an Asian cohort: Results from the K-ROAD registry (P265) Blood and CSF biomarkers Poster Thu Nov 19 7:15am–5:00pm Cardiovascular changes during lecanemab treatment and subsequent amyloid-related imaging abnormalities (P474) Anti-amyloid and anti-tau therapies · Real-world data and access

Organization

CTAD 2026 Attendance

Samsung Medical Center

Seoul, South Korea

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Burden-dependent bias of cerebellar reference regions in amyloid PET monitoring of disease-modifying therapy: eroded white matter as a calibratable anchor (P096)

PET and MRI imaging

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Stronger Association of PM2.5 Exposure with Early-Onset Alzheimer’s Disease and Distinct Vulnerability Profiles: A Nationwide 16-Year Cohort Study with Supporting Evidence from iPSC-Derived Neurons (P162)

Prevention and early disease

Poster

Wed Nov 18
7:15am–5:30pm

Temporal plasma proteomic responses to lecanemab and their associations with amyloid clearance and cognitive change: a multicentre, real-world cohort study (P227)

Anti-amyloid and anti-tau therapies · Blood and CSF biomarkers

Poster

Wed Nov 18
7:15am–5:30pm

Diagnostic accuracy of Elecsys pTau181 and pTau217 plasma assays using global cutoffs in an Asian cohort: Results from the K-ROAD registry (P265)

Blood and CSF biomarkers

Poster

Thu Nov 19
7:15am–5:00pm

Cardiovascular changes during lecanemab treatment and subsequent amyloid-related imaging abnormalities (P474)

Anti-amyloid and anti-tau therapies · Real-world data and access

Instantly find 20 buyers from Samsung Medical Center

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction